Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy.

Fifty percent of PLWH survived five years after HCC diagnosis; 90.9% among OLT patients. Recurrence after IT was observed in 46% of HCC/PLWH. AFP cut-off levels of 28.8 ng/mL were the only independent variable associated with survival.